CareDx, Inc (CDNA)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in CareDx, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

CareDx, Inc (CDNA) has returned -7.86% so far this year and -2.20% over the past 12 months. Looking at the last ten years, CDNA has achieved an annualized return of 12.99%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Jul 17, 2014, CDNA's average daily return is +0.14%, while the average monthly return is +2.92%. At this rate, your investment would double in approximately 2.0 years.

Historically, 52% of months were positive and 48% were negative. The best month was Aug 2017 with a return of +115.0%, while the worst month was Mar 2023 at -45.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.

On a daily basis, CDNA closed higher 49% of trading days. The best single day was May 4, 2017 with a return of +35.6%, while the worst single day was Sep 28, 2015 at -40.9%.

CareDx, Inc has an annualized alpha of 20.80%, beta of 1.35, and R² of 0.10 versus S&P 500 Index. Calculated based on daily prices since July 18, 2014.

• This stock captured 192.46% of S&P 500 Index gains and 185.18% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.10 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CDNA ranks 39 for risk / return — below 39% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for CareDx, Inc (CDNA) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the CareDx, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CareDx, Inc was 94.87%, occurring on Oct 25, 2023. The portfolio has not yet recovered.

The current CareDx, Inc drawdown is 81.84%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of CareDx, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how CareDx, Inc is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.